source
- Axsome secures settlement to keep Sunosi exclusive until 2040Axsome Therapeutics announced it has reached a settlement that pushes back the entry of generic versions of its narcolepsy medication Sunosi until 2040. The agreement was reached with the last rem…
- Alnylam inks up to $2 billion AI partnership with Inceptive Nucleics for RNAi drug discoveryAlnylam announced a three-year strategic collaboration with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The agreement is valued at up to $2 billion, with an initial $…